0001213900-26-093018.txt : 20260824 0001213900-26-093018.hdr.sgml : 20260824 20260824160514 ACCESSION NUMBER: 0001213900-26-093018 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260824 DATE AS OF CHANGE: 20260824 EFFECTIVENESS DATE: 20260824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NewcelX Ltd. CENTRAL INDEX KEY: 0001783036 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595172 FILM NUMBER: 261310530 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: THE CIRCLE 6 STREET 2: 8058 CITY: ZURICH PROVINCE COUNTRY: V8 BUSINESS PHONE: 41-41-618-80-00 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: THE CIRCLE 6 STREET 2: 8058 CITY: ZURICH PROVINCE COUNTRY: V8 FORMER COMPANY: FORMER CONFORMED NAME: NLS Pharmaceutics Ltd. DATE OF NAME CHANGE: 20190719 D 1 primary_doc.xml X0708 D LIVE 0001783036 NewcelX Ltd. HOHSTRASSE 1 KLOTEN V8 SWITZERLAND 8302 41 44 512 21 50 SWITZERLAND None NLS Pharmaceutics Ltd. Other Company incorporated in Switzerland true Ronen Twito NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Executive Officer Director Executive Chairman and Chief Executive Officer Michel Revel NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Executive Officer Director Kfir Molakandov NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Executive Officer Omri Hagai NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Executive Officer Chief Financial Officer Alexander C. Zwyer NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Executive Officer Director Olivier Samuel NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Director Eran Iohan NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Director Liora Oren NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Director Tamar Galili NewcelX Ltd. Hohstrasse 1 Kloten V8 SWITZERLAND 8302 Director Biotechnology Decline to Disclose 06b false 2026-07-03 true true true true true Common shares and warrants to purchase common shares false 0 None None None None None None None XX Unknown 000000 CA CALIFORNIA true 2940234 2940234 0 Including the exercise price of common shares underlying such warrants at an exercise price of $4.437. false 5 0 0 0 false NewcelX Ltd. /s/ Ronen Twito Ronen Twito Chief Executive Officer 2026-08-24